Atellica System
Brand(s)
Last updated
Summary
Product
Atellica System
Issue
Medical devices - Inaccurate test or measurement results
What to do
Contact the manufacturer if you require additional information.
Affected products
| Affected Products | Lot or Serial Number | Model or catalog number |
|---|---|---|
| Atellica Im Enhanced Estradiol (Ee2) | All lots. | 10995562, 10995561 |
| Advia Centaur System - Enhanced Estradiol (Ee2) Assay | All lots. | 10490889, 10491445 |
| Advia Centaur Cp System - Enhanced Estradiol (Ee2) Assay | All lots. | 10490889, 10491445 |
Issue
Siemens Healthcare Diagnostics Inc. has confirmed customer observations of falsely elevated results when using plasma specimens across the entire analytical measuring range (AMR) with the Atellica IM enhanced estradiol (EE2) assay. Results demonstrate that plasma specimens are not meeting claims as defined in the instructions for use (IFU). limited data is available at this time as the investigation for this issue is on-going.
Recall start date: Mar 9, 2022
Additional information
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - Cardiovascular
Health products - Medical devices - Chemistry
Companies
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave, Tarrytown, New York
United States, 10591
Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type II
Identification number
RA-63995
Get notified
Receive emails about new and updated recall and safety alerts.